SCHEMBL16616247

SCHEMBL16616247

COc1ccc(C(=O)/C=C/c2cccnc2Nc2ccc(Cl)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.50
POLB P06746 3/20 0.50
MAPK1 P28482 2/20 0.50
DPP4 P27487 1/20 0.49
PREP P48147 1/20 0.49
DPP9 Q86TI2 1/20 0.49
LMNA P02545 7/20 0.48
ALDH1A1 P00352 5/20 0.48
NPSR1 Q6W5P4 2/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
ABCG2 Q9UNQ0 2/20 0.47
NPC1 O15118 2/20 0.47
CYP3A4 P08684 2/20 0.47
HPGD P15428 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16616250 1.00 MAPT (0.50) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616377 0.92 MAPT (0.51) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616830 0.92 MAPT (0.49) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616376 0.92 MAPT (0.51) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16625587 0.92 ALDH1A1 (0.49) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616827 0.92 MAPT (0.49) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616474 0.92 KMT2A (0.55) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616476 0.92 KMT2A (0.55) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616395 0.91 LMNA (0.48) MAPTPOLBMAPK1DPP4PREP
SCHEMBL16616394 0.91 LMNA (0.48) MAPTPOLBMAPK1DPP4PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof HCCS, WEE2, WEE1 MAPT 2681/4885POLB 2850/4885MAPK1 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.